Ambit Biosciences

Company
Corporation
Thing
Organization
Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California and consisted of a single facility. Ambit made an initial public offering in May 2013 and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange.
Ambit Biosciences
Definition
Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California and consisted of a single facility. Ambit made an initial public offering in May 2013 and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange.
Ambit Biosciences
Ambit Biosciences
Ambit was an American pharmaceutical company focused on development of kinase inhibitor therapeutics to treat a variety of human diseases. As of March 2014, the company was based in San Diego, California and consisted of a single facility. Ambit made an initial public offering in May 2013 and was listed on the NASDAQ exchange under the symbol "AMBI". Ambit was acquired by Daiichi Sankyo in 2014 and is no longer traded on the NASDAQ exchange.
New to Cofactor?

Cofactor is a large, structured listing of people, places, and things. Here you can find the definition of each subject.

Your Cofactor profile
Sign up for an account to create your personal profile.